Treating Mesothelioma with Chemotherapy vs. Immunotherapy
Learn everything you need to know about treating mesothelioma with chemotherapy versus immunotherapy. Medical oncologist Dr. J. Marie Suga discusses the key differences between the two treatment types, what to expect when getting chemotherapy or immunotherapy and who typically responds better to each type of treatment.
Learn about chemotherapy versus immunotherapy for mesothelioma treatment. In this free presentation, medical oncologist Dr. J. Marie Suga discusses key differences between the two treatment types and who typically responds better to each type of treatment.
-
J. Marie Suga, MDMedical Oncologist and Mesothelioma Specialist -
Sean Marchese, MS, RNOncology Medical Writer and Registered Nurse
What You’ll Learn During the Webinar
Medical oncologist Dr. J. Marie Suga presents information on chemotherapy and immunotherapy for mesothelioma treatment. Topics include:
- Top mesothelioma treatments
- Chemotherapy versus immunotherapy as a first-line mesothelioma treatment
- Current chemotherapy options for treating mesothelioma
- Immunotherapy options for mesothelioma patients
- Factors to consider when evaluating treatment
You’ll also receive access to the free Q&A session our experts hosted after the presentation.
Hear from a Top Mesothelioma Specialist
Medical oncologist Dr. J. Marie Suga and registered nurse Sean Marchese have spent years helping mesothelioma patients and their families. Dr. Suga is an oncologist at Kaiser Permanente Vallejo Medical Center in California. Nurse Marchese helps patients learn about new treatments in the fight against mesothelioma.-
J. Marie Suga, MDAs an oncologist at Kaiser Permanente Vallejo Medical Center in California, Dr. J. Marie Suga serves as the medical director for the Kaiser Permanente Clinical Trials Program. She specializes in treating patients with lung cancer, breast cancer, colorectal cancer and malignant pleural mesothelioma. -
Sean Marchese, MS, RNAs a registered nurse with more than 20 years in clinical experience and more than six years in clinical research, Sean Marchese has planned and led oncology clinical trials involving immunotherapy, chemotherapy, radiation therapy and tumor treating fields. He has been a member of the American Nurses Association since 2017.
Disclaimer: The content of this website is not intended as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician about questions you may have regarding your medical condition.
